11:05 AM

Sponsored by: Site Feasibility of the Future—Site Intelligence from the Source

Access to site performance data is transforming how we evaluate and qualify clinical trial sites. By integrating these insights with feasibility workflows, sponsors and CROs can achieve a more holistic, data-driven approach that reduces site burden, accelerates decision-making, and redefines site feasibility for the future.

12:45 PM

Sponsored by: How Data-Driven Sites Are Proving Patient Access to Win Trials and Accelerate Enrollment

Clinical research is entering a new era, where data transparency and AI are beginning to reshape how sponsors evaluate and select site partners. As sites start to invest in AI-powered tools and explore ways to leverage their own patient-level data, they’re positioning themselves to demonstrate proven patient access, differentiate their capabilities, and build sponsor confidence — even before a trial begins.

This session will explore how forward-thinking sites are laying the groundwork to become more data-driven. Panelists will discuss the value of investing in AI and patient data, share how they’re beginning to approach this shift, and reflect on how these efforts can support faster, more informed decisions with sponsors.

3:55 PM

Sponsored by: Start with Patients, End with Confidence: Rewiring Feasibility for Real‑World Enrollment

Feasibility breaks when it relies on protocol assumptions instead of real-world patient access. This session reframes feasibility as a patient-first discipline—one that starts with understanding who and where eligible patients truly are. Using a Phase 3 pancreatic cancer study as an example, we’ll show how AI-powered analysis of RWD, protocol viability, and predictive site intelligence surfaced restrictive criteria, expanded eligibility by 15–20%, and identified overlooked investigators within 48 hours. Attendees will learn practical steps to validate protocol feasibility, pressure-test enrollment assumptions with data-driven forecasts, diversify site networks, and set early guardrails that surface risk before timelines slip. The result is a repeatable, confidence-building approach without added complexity.

4:20 PM

Sponsored by: Winning Together: Smarter Access for Sites & Sponsors

We hear you. Sponsors are challenged with lengthy study start-up processes and ongoing monitoring, while the clinical trial sites are burdened with technology redundancy and sign-on silos obstacles. In this talk, we will give the sponsor's and site's perspective on the progress made to overcome these issues and share real examples of how sponsors and sites are collaborating and streamlining the user’s experience.

4:32 PM

Sponsored by: Five-Minute Feasibility—Too Good to Be True?

Traditional feasibility in clinical trials is slow, manual, and costly—often delaying study start-up and driving frequent amendments. This session will explore how innovative, data-driven approaches can transform feasibility assessments into faster, smarter, and more accurate processes, reducing timelines, optimizing budgets, and ultimately accelerating patients’ access to new treatments.

8:00 AM

BREAFAST PRESENTATION OPTION #1:
Sponsored by: Reaching the Unreachable: Proven Strategies You Can Apply to Engage Underserved Populations in Global Clinical Trials

Underserved populations are often excluded from clinical trials, limiting engagement, scientific validity, and real-world relevance. Traditional strategies often rely on outdated assumptions and overlook patient realities. This session reveals proven, globally scalable strategies to engage these communities through real-world data (RWD), behavioral insights, and human-centered approaches—replacing guesswork with precision to accelerate inclusive trial enrollment and shorten study timelines.

8:00 AM

BREAKFAST PRESENTATION OPTION #2:
Sponsored by: From Elusive to Enrolled: A Case Study in Precision Recruitment 

As the pace of innovation accelerates, scientific breakthroughs bring new hope to patients. Effectively including and supporting underrepresented populations is critical for the success of clinical trials designed to benefit these communities. GCI Health’s experts will share their “secret sauce” for building meaningful engagement with niche communities along with a real-world example of its methodology in action through its work with the University of Florida’s traumatic brain injury trial.

9:00 AM

Sponsored by: Feasibility & Start-Up Risk in Practice: Managing What Emerges

In clinical development, the path from feasibility to first patient is like entering a dense forest—you rarely see the full trail from the start. Blind spots such as compressed feasibility, tech gaps, and overreliance on imperfect data derail timelines. This session reveals the myths, risks, and practical plays to keep studies on track. Join us to learn how to spot hidden obstacles and build adaptive strategies before delays appear.

9:50 AM

Sponsored by: Laying the Process Groundwork to Achieve a 24-Hour Study Build

Zelta by Merative, in partnership with Alimentiv, will explore how to optimize study-start-up processes as a key enabler and accelerator in creating an end-to-end vision for how Digital Data Flow (DDF) can impact the industry. Discover practical strategies to reimagine your clinical trial processes through advanced technology that supports protocol ingestion, AI-informed design, smart validation, and standards-informed data flow—accelerating validated study builds within 24 hours.

11:15 AM

Sponsored by:  Why Your Site Feasibility Strategy Is Failing—and How AI Can Fix It

Feasibility teams operate on outdated assumptions, like experience equals better performance and public site data is reliable. Analysis of 12,000 clinical trial sites reveals 43% never enroll a single patient and in 80% of studies, site experience doesn’t correlate to enrollment success. This session debunks myths and shows why site-specific, indication-level performance data is necessary to improve site selection, reduce non-enrollers, and turn feasibility into a competitive advantage.

12:30 PM

Sponsored by: Precision Feasibility: Data-Driven Planning across Program, Trial & Site to Reduce Burden and Optimize Site Selection

Explore how strategic data use across program, trial, and site-level feasibility planning can streamline clinical trial execution. Learn how to reduce site burden by eliminating repetitive queries and ensure site selection aligns with the unique needs of the molecule and trial strategy. This session highlights how differentiated feasibility layers—program, trial, and site—can work together to drive smarter, more efficient planning.

8:00 AM

BREAKFAST PRESENTATION:
Sponsored by: From Burden to Breakthrough: Innovative Strategies for Site and Patient Support

This presentation explores strategies to strengthen clinical trial site capacity and improve patient engagement. It emphasizes delivering customized solutions through specialized roles that integrate with site teams, flexible resourcing, and operational support across key activities such as prescreening, recruitment, data entry, and remote study visits. Additionally, it highlights the importance of global scalability combined with local expertise, supported by an oversight structure that ensures consistency worldwide. The ultimate goal is to drive measurable improvements in site performance, operational efficiency, patient engagement, and retention, creating a more effective and patient-centric trial experience.

9:00 AM

Sponsored by: Is AI Enough? Why Smarter Site Identification Still Needs Human-Centred Strategies

Artificial intelligence has transformed site identification, helping sponsors find high-performing sites faster. ICON’s OneSearch uses predictive analytics and historical data to speed feasibility—but AI alone can’t solve study start up challenges. Finding the “right site” is just the start. With demand exceeding site capacity, success requires creating value for site partners, addressing real constraints, and building sustainable site communities. This session explores ICON’s five year evolution combining AI with human centred strategies.

9:50 AM

Sponsored by: From Spec to First Patient: Fast-Tracking Global eCOA & eConsent Deployment

Global trial feasibility now requires eConsent and eCOA readiness from first patient in every country. Translation, licensing, ethics, and device issues can delay sites and fragment data. This session shows how integrated operational, linguistic, and technical planning - supported by RWS’s scale and Castor’s validated, automated, device‑ready platform - enables fast, harmonized global site activation.

12:00 PM

Sponsored by: Optimizing Clinical Trials: Leveraging Payer Insights and Real-World Data for Recruitment and Site Planning

In an industry where 85% of clinical trials fail to recruit or retain enough participants, precision targeting is crucial. This session explores how robust pharmacy and medical claims data – enhanced by payer insights – can be used to rapidly identify patient cohorts that match detailed study criteria and pinpoint where those patients reside. By leveraging real-world data and payer insights in study planning, sponsors can avoid protocol revisions and costly delays. Attendees will learn how a data-driven approach to clinical criteria and site selection ensures that only the most relevant patients enter the pipeline. Attendees will learn how data-driven clinical criteria and site selection ensures only the most relevant patients enter the pipeline, and they will understand how payer-informed targeting and outreach improves speed, scalability and overall trial performance.